NCCAM intramural research
This article was originally published in The Tan Sheet
NIH center launches first clinical trial under Division of Intramural Research June 12; study will explore whether electroacupuncture reduces delayed nausea of cancer patients after chemotherapy. Other planned initiatives include examining "effects of DHEA and/or phytoestrogens on neurobehavioral, immunological and endocrine-metabolic functions in healthy, depressed and cognitively impaired aged individuals" and evaluating "effects of carnitine on hypothalamic-pituitary-adrenal function in healthy and depressed individuals," according to 1NCCAM Web site...
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."